Clinical Trials · NCT05189457
First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Enrollment
- 32
- Start date
- Jan 2022
- Locations
- 1 site, United States
- Primary endpoint
- Overall Survival